Laboratoris Sanifit Adds Board Member
Laboratoris Sanifit SL has appointed Keith R. Leonard, former president and CEO of Kythera Biopharmaceuticals Inc., to its board of directors. Leonard brings over 20 years of industry experience to the Spanish company, which focuses on treatments for calcification disorders. Prior to co-founding Kythera in 2005, Leonard held various positions at Amgen Inc., including senior vice president and general manager of Amgen Europe. He currently serves on the board of several other companies, and is the executive chairman of UNITY Biotechnology and Sienna Biopharmaceuticals.
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.